ABO 0 3 0 3 B-clinical_variable
compatibility 4 17 4 17 O
in 18 20 18 20 O
the 21 24 21 24 O
host 25 29 25 29 O
vs. 30 33 30 33 O
graft 34 39 34 39 O
direction 40 49 40 49 O

Contraindication 0 16 50 66 O
to 17 19 67 69 O
therapy 20 27 70 77 B-treatment
with 28 32 78 82 O
any 33 36 83 86 O
one 37 40 87 90 O
of 41 43 91 93 O
the 44 47 94 97 O
proposed 48 56 98 106 O
agents 57 63 107 113 O
( 64 65 114 115 O
e.g. 65 69 115 119 O
, 69 70 119 120 O
history 71 78 121 128 O
of 79 81 129 131 O
allergy 82 89 132 139 B-allergy_name
to 90 92 140 142 O
rabbit 93 99 143 149 B-allergy_name
serum 100 105 150 155 I-allergy_name
in 106 108 156 158 I-allergy_name
ATG 109 112 159 162 I-allergy_name
) 112 113 162 163 O

Existence 0 9 164 173 O
of 10 12 174 176 O
haploidentical 13 27 177 191 B-treatment
first 28 33 192 197 O
degree 34 40 198 204 O
relative 41 49 205 213 O
who 50 53 214 217 O
passes 54 60 218 224 O
standard 61 69 225 233 O
donor 70 75 234 239 O
evaluations 76 87 240 251 O
for 88 91 252 255 O
bone 92 96 256 260 O
marrow 97 103 261 267 O
and 104 107 268 271 O
kidney 108 114 272 278 O
donation 115 123 279 287 O

FEV1 0 4 288 292 B-clinical_variable
, 4 5 292 293 O
FVC 6 9 294 297 B-clinical_variable
, 9 10 297 298 O
and 11 14 299 302 O
DLCO 15 19 303 307 B-clinical_variable
> 20 21 308 309 O
50 22 24 310 312 B-lower_bound
% 24 25 312 313 I-lower_bound
of 26 28 314 316 O
predicted 29 38 317 326 O
as 39 41 327 329 O
measured 42 50 330 338 O
by 51 53 339 341 O
standard 54 62 342 350 O
PFTs 63 67 351 355 O

LVEF 0 4 356 360 B-clinical_variable
> 5 6 361 362 O
40 7 9 363 365 B-lower_bound
% 9 10 365 366 I-lower_bound
as 11 13 367 369 O
measured 14 22 370 378 O
by 23 25 379 381 O
echocardiography 26 42 382 398 B-treatment
or 43 45 399 401 O
MUGA 46 50 402 406 B-treatment

Life 0 4 407 411 B-clinical_variable
expectancy 5 15 412 422 I-clinical_variable
greater 16 23 423 430 O
than 24 28 431 435 O
six 29 32 436 439 B-lower_bound
months 33 39 440 446 I-lower_bound

Men 0 3 447 450 B-gender
and 4 7 451 454 I-gender
women 8 13 455 460 I-gender
of 14 16 461 463 O
reproductive 17 29 464 476 O
potential 30 39 477 486 O
must 40 44 487 491 O
agree 45 50 492 497 B-contraception_consent
to 51 53 498 500 I-contraception_consent
use 54 57 501 504 I-contraception_consent
a 58 59 505 506 I-contraception_consent
reliable 60 68 507 515 I-contraception_consent
method 69 75 516 522 I-contraception_consent
of 76 78 523 525 I-contraception_consent
birth 79 84 526 531 I-contraception_consent
control 85 92 532 539 I-contraception_consent
during 93 99 540 546 O
the 100 103 547 550 O
treatment 104 113 551 560 B-treatment
, 113 114 560 561 O
and 115 118 562 565 O
women 119 124 566 571 O
should 125 131 572 578 O
do 132 134 579 581 O
so 135 137 582 584 O
for 138 141 585 588 O
a 142 143 589 590 O
period 144 150 591 597 O
of 151 153 598 600 O
1 154 155 601 602 B-upper_bound
year 156 160 603 607 I-upper_bound
following 161 170 608 617 O
the 171 174 618 621 O
transplant 175 185 622 632 B-treatment

Participants 0 12 633 645 O
should 13 19 646 652 O
be 20 22 653 655 O
on 23 25 656 658 O
dialysis 26 34 659 667 B-treatment
or 35 37 668 670 O
have 38 42 671 675 O
an 43 45 676 678 O
estimated 46 55 679 688 O
or 56 58 689 691 O
measured 59 67 692 700 O
CrCl 68 72 701 705 B-clinical_variable
< 73 74 706 707 O
35 75 77 708 710 B-upper_bound
ml 78 80 711 713 I-upper_bound
/ 80 81 713 714 I-upper_bound
min 81 84 714 717 I-upper_bound

Participation 0 13 718 731 O
in 14 16 732 734 O
other 17 22 735 740 O
investigational 23 38 741 756 B-treatment
drug 39 43 757 761 I-treatment
use 44 47 762 765 O
at 48 50 766 768 O
the 51 54 769 772 O
time 55 59 773 777 O
of 60 62 778 780 O
enrollment 63 73 781 791 O

Serologic 0 9 792 801 O
positivity 10 20 802 812 O
for 21 24 813 816 O
HIV 25 28 817 820 B-chronic_disease
, 28 29 820 821 O
HCV 30 33 822 825 B-chronic_disease
, 33 34 825 826 O
or 35 37 827 829 O
HbsAg 38 43 830 835 B-chronic_disease
positivity 44 54 836 846 O

This 0 4 847 851 O
includes 5 13 852 860 O
, 13 14 860 861 O
but 15 18 862 865 O
is 19 21 866 868 O
not 22 25 869 872 O
limited 26 33 873 880 O
to 34 36 881 883 O
: 36 37 883 884 O
acute 38 43 885 890 B-cancer
myeloid 44 51 891 898 I-cancer
leukemia 52 60 899 907 I-cancer
( 61 62 908 909 I-cancer
AML 62 65 909 912 I-cancer
) 65 66 912 913 I-cancer
, 66 67 913 914 O
acute 68 73 915 920 B-cancer
lymphoblastic 74 87 921 934 I-cancer
leukemia 88 96 935 943 I-cancer
( 97 98 944 945 I-cancer
ALL 98 101 945 948 I-cancer
) 101 102 948 949 I-cancer
, 102 103 949 950 O
chronic 104 111 951 958 B-cancer
myelogenous 112 123 959 970 I-cancer
leukemia 124 132 971 979 I-cancer
( 133 134 980 981 I-cancer
CML 134 137 981 984 I-cancer
) 137 138 984 985 I-cancer
, 138 139 985 986 O
chronic 140 147 987 994 B-cancer
lymphocytic 148 159 995 1006 I-cancer
leukemia 160 168 1007 1015 I-cancer
( 169 170 1016 1017 I-cancer
CLL 170 173 1017 1020 I-cancer
) 173 174 1020 1021 I-cancer
, 174 175 1021 1022 O
non 176 179 1023 1026 B-cancer
- 179 180 1026 1027 I-cancer
Hodgkin 180 187 1027 1034 I-cancer
lymphoma 188 196 1035 1043 I-cancer
( 197 198 1044 1045 I-cancer
NHL 198 201 1045 1048 I-cancer
) 201 202 1048 1049 I-cancer
, 202 203 1049 1050 O
Hodgkin 204 211 1051 1058 O
lymphoma 212 220 1059 1067 O
, 220 221 1067 1068 O
multiple 222 230 1069 1077 B-cancer
myeloma 231 238 1078 1085 I-cancer
( 239 240 1086 1087 I-cancer
MM 240 242 1087 1089 I-cancer
) 242 243 1089 1090 I-cancer
, 243 244 1090 1091 O
myelodysplastic 245 260 1092 1107 B-cancer
syndrome 261 269 1108 1116 I-cancer
( 270 271 1117 1118 I-cancer
MDS 271 274 1118 1121 I-cancer
) 274 275 1121 1122 I-cancer
, 275 276 1122 1123 O
AL 277 279 1124 1126 B-chronic_disease
amyloidosis 280 291 1127 1138 I-chronic_disease
, 291 292 1138 1139 O
diamond 293 300 1140 1147 B-chronic_disease
blackfan 301 309 1148 1156 I-chronic_disease
anemia 310 316 1157 1163 I-chronic_disease
, 316 317 1163 1164 O
myelofibrosis 318 331 1165 1178 B-cancer
or 332 334 1179 1181 O
other 335 340 1182 1187 O
myeloproliferative 341 359 1188 1206 B-cancer
disease 360 367 1207 1214 I-cancer
, 367 368 1214 1215 O
sickle 369 375 1216 1222 B-chronic_disease
cell 376 380 1223 1227 I-chronic_disease
anemia 381 387 1228 1234 I-chronic_disease
, 387 388 1234 1235 O
and 389 392 1236 1239 O
thalassemia 393 404 1240 1251 B-chronic_disease

Total 0 5 1252 1257 B-clinical_variable
bilirubin 6 15 1258 1267 I-clinical_variable
< 16 17 1268 1269 O
2.0 18 21 1270 1273 B-upper_bound
( 22 23 1274 1275 O
unless 23 29 1275 1281 O
diagnosis 30 39 1282 1291 O
of 40 42 1292 1294 O
Gilbert 43 50 1295 1302 B-chronic_disease
's 50 52 1302 1304 I-chronic_disease
or 53 55 1305 1307 O
hemolysis 56 65 1308 1317 B-chronic_disease
is 66 68 1318 1320 O
made 69 73 1321 1325 O
) 73 74 1325 1326 O
and 75 78 1327 1330 O
AST 79 82 1331 1334 B-clinical_variable
, 82 83 1334 1335 O
ALT 84 87 1336 1339 B-clinical_variable
, 87 88 1339 1340 O
alkaline 89 97 1341 1349 B-clinical_variable
phosphatase 98 109 1350 1361 I-clinical_variable
all 110 113 1362 1365 O
< 114 115 1366 1367 O
5x 116 118 1368 1370 B-upper_bound
institutions 119 131 1371 1383 I-upper_bound
upper 132 137 1384 1389 I-upper_bound
limit 138 143 1390 1395 I-upper_bound
of 144 146 1396 1398 I-upper_bound
normal 147 153 1399 1405 I-upper_bound

Underlying 0 10 1406 1416 O
hematological 11 24 1417 1430 B-chronic_disease
disorder 25 33 1431 1439 I-chronic_disease
which 34 39 1440 1445 O
is 40 42 1446 1448 O
potentially 43 54 1449 1460 O
curable 55 62 1461 1468 O
with 63 67 1469 1473 O
allogeneic 68 78 1474 1484 B-treatment
bone 79 83 1485 1489 I-treatment
marrow 84 90 1490 1496 I-treatment
transplantation 91 106 1497 1512 I-treatment

ages 0 4 1513 1517 B-age
18 5 7 1518 1520 B-lower_bound
- 7 8 1520 1521 O
70 8 10 1521 1523 B-upper_bound

